Company intelligence / Profile preview

Rhythm AI

London, England, United Kingdomrhythm-ai.com ↗

Ownership: Private
Development stage: Commercial

Overview

Rhythm AI has developed the STAR Apollo Mapping System, an FDA-cleared platform that uses advanced artificial intelligence algorithms to analyze real-time electrophysiology data and map atrial fibrillation drivers. This enables more precise identification and treatment of arrhythmogenic areas in the heart, supporting personalized ablation strategies for patients with atrial fibrillation. The system is now being used clinically, including with pulsed field ablation technologies.

Therapeutic areas: Cardiovascular
Modalities: DeviceSoftware (AI-powered cardiac mapping system)
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Rhythm AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rhythm AI.

Explore the full profile